INTRODUCTION
Neurons represent the basic functional units of the nervous system and are unique in many aspects, including their morphological and physiological properties (Kawaguchi, 1993; Pennartz et al., 1998; Faber et al., 2001; Hamam et al., 2002) . A comprehensive, transcriptome-based deconvolution of complex tissue into cellular subtypes is required to better understand cellular mechanisms and behavior in healthy, developmental, and disease states. Several approaches have been developed to profile individual neurons at the physiological and molecular level. In the past, the combination of patch-clamp with single-cell reverse transcription PCR (Eberwine et al., 1992; Lambolez et al., 1992; Cauli et al., 1997; Sucher et al., 2000; Toledo-Rodriguez et al., 2004; Weng et al., 2010; Citri et al., 2011; Belinsky et al., 2014) or microarray (Subkhankulova et al., 2010) techniques has enabled the correlation of cellular function with gene expression patterns. These techniques, however, only provide a snapshot of the expression of a limited number of pre-specified genes, precluding an unbiased discovery of novel transcripts and splice variants. With the recent advances in whole-transcriptome amplification and next-generation sequencing methods, the profiling of singlecell transcriptomes by RNA sequencing (i.e., scRNA-seq) has become a promising and prevailing approach to define and disentangle in greater detail the heterogeneity of cell types (Eberwine et al., 2014) .
To identify molecular features associated with specific neuronal functions and phenotypes, we and others have combined scRNA-seq profiling with electrophysiological and morphological characterization of individual neurons in a method referred to as Patch-seq Cadwell et al., 2016; Chen et al., 2016; Foldy et al., 2016; Fuzik et al., 2016; Cadwell et al., 2017) . Neurological or psychiatric disease-specific abnormalities generally manifest only in particular (sub)types of neurons or at specific maturational stages, and Patch-seq provides the resolution to identify such unique cell types (Stahlberg et al., 2011; Eberwine et al., 2014) . Unlike more automated single-cell capture techniques (e.g., microfluidics systems or droplet-based sequencing approaches), Patch-seq enables the transcriptome data to be linked to quantifiable neurophysiological phenotypes (electrophysiology and neuro-morphology).
Here, we describe our Patch-seq protocol, which we previously validated in a thorough analysis of human iPSC-derived neurons from healthy subjects . In contrast to other published approaches (Cadwell et al., 2016; Fuzik et al., 2016; Cadwell et al., 2017 ; Table 1), our protocol includes the analysis of cytosolic RNA as well as distant RNA in the dendrites and axon. Microscopic examination demonstrates that the entire neuronal soma and the neurites (≥150 µm distance away from the cell body) are collected with our approach. By including transcripts from adjacent neurites, this method presumably provides a more accurate representation of the complete transcriptional program of the cell (Cajigas et al., 2012) , making it potentially valuable for studying neurobiological mechanisms or disorders relying on distal synaptic/dendritic mRNA trafficking (Bagni and Greenough, 2005; Bassell and Warren, 2008) . The method is particularly well suited for the collection of single neurons cultured in a petri dish or on a glass coverslip, such as in vitro stem cell-derived neurons or primary neurons.
To confirm successful collection of the entire neuron and to ensure that only one cell is captured in each sample, our neuronal isolation method with a micropipette relies on visual microscopic confirmation. Following collection of a single neuron, the sample is immediately processed for cDNA synthesis and amplification, thereby avoiding any possible degradation of the picogram amounts of mRNA and optimizing the accuracy of acquiring a snapshot of the single-cell transcriptome. Procedural effects on cell molecular profiles are minimized as the neurons remain functional in their spatial context and environmental niche until the final collection step, which can be completed in under a minute. In contrast, microfluidic devices used to collect single cells for scRNA-seq are more disruptive to the cells (i.e., neurons dissociated with cut dendrites) and ultimately less accurate than the Patch-seq protocol described here. However, automated microfluidic systems can be a valuable complement to Patchseq by providing a less labor-intensive and higher throughput analysis of single-cell transcriptomic profiles.
A thorough quality control (QC) analysis of Patch-seq is performed on each reverse-transcribed and PCR-amplified sample prior to library preparation and deep transcriptome Bardy et al. (2016) Patch-seq Cadwell et al. (2016 Cadwell et al. ( , 2017 Patch-seq Fuzik et al. (2016) sequencing to identify and filter out spurious captures and contaminated cell samples. The QC pipeline described here is based on (i) expression profiling of common housekeeping genes and differentially abundant exogenous reference transcripts (ERCC spike-in controls), (ii) fluorometric quantitation of cDNA yield (Qubit), and (iii) qualitative analysis of cDNA fragment profiles (Agilent Bioanalyzer).
Current and Future Applications of Patch-seq
Patch-seq analysis allows correlation between gene expression profiles, physiological function, and morphology of single cells. So far, Patch-seq has been successfully applied to human neuronal cultures in vitro and ex vivo rodent brain slices (Cadwell et al., 2016; Fuzik et al., 2016) . In the future, Patchseq analysis might also be used to profile live human neurons obtained from patients via surgical biopsy. The application of Patch-seq for multimodal classification of neuronal types in the mouse brain (Cadwell et al., 2016; Fuzik et al., 2016) is very likely to complement global efforts in classifying all the cell types in the human brain (Ecker et al., 2017) . To further elucidate neuronal circuitry structure and function, Patch-seq performed on rodent brain slices may be combined with optical tools or synapsespecific trans-neuronal tracing methods (Ginger et al., 2013; Kim et al., 2016) to interrogate the transcriptome of neurons receiving inputs from, or projecting to, specific areas in the brain. Patch-seq has also been used to study human neurodevelopmental mechanisms with iPSCs in vitro and, in the future, is very likely to serve investigation aiming to decipher a wide range of fundamental cellular mechanisms in both health and disease. Intra-and inter-donor sample variability in RNA-seq experiments is a serious challenge and we believe that Patch-seq can help addressing this by reducing the heterogeneity of cell types in transcriptomic analysis (Hoffman et al., 2017) . Finally, Patch-seq may be extended to non-neuronal cells which are electrophysiologically interesting, such as iPSC-derived cardiomyocytes, which can also be cultured on coverslips (Ma et al., 2011; Davis et al., 2012) .
Advantages of Patch-seq Analysis of Human Pluripotent Stem Cell-Derived Neurons in vitro
The approach we developed to thoroughly analyze the phenotypes of human ESC/iPSC-derived neurons in vitro using Patch-seq is innovative and sets a new standard for neurobiological analysis in the following ways:
• Enabling a precise identification and multimodal characterization of cellular subtypes. Patch-seq provides a complete phenotypic analysis, including electrophysiology, morphology, and transcriptomic profiles of single neurons. Cell biological functions are intertwined and depend on each other, and Patch-seq multimodal profiling of single cells will allow thorough analysis of inter-dependent neurobiological processes.
• Resolving bias from bulk analysis of cells/tissues. En masse pooling and analysis of cells obscures subpopulations and does not accurately reflect the biological changes that happen at the single-cell level (Toriello et al., 2008; Wills et al., 2013; Patel et al., 2014; Sandberg, 2014) . Combining electrophysiological and morphological analysis of single neurons with single-cell expression profiling provides the resolution required for identifying rare or clinically important cell types and the aberrant molecular mechanisms associated with them (Stahlberg et al., 2011; Eberwine et al., 2014 ).
• Eliminating bias resulting from variability in tissue culture conditions. A major hurdle to overcome in using human iPSC disease models is inherent tissue culture variability. In particular, human neuronal models, which require extended time for maturation in vitro (>1 month), are inherently variable and are often characterized by a considerably heterogeneous proportion of functionally mature neurons . In combination with rigorous control and optimization of overall tissue culture conditions, a molecular analysis of neurons pre-characterized with patch clamping accelerates the discovery of new neuron type-specific biomarkers, which can be used to reduce immanent phenotypic variability and streamline more accurate investigations in higher throughput fashion.
MATERIALS AND EQUIPMENT

Reagents
Coverslip Preparation and Coating Reagents
• Nitric acid (Sigma-Aldrich, 4388073)
• Caution: Nitric acid is extremely corrosive; handle with care and use appropriate personal protective equipment.
• Hydrochloric acid (Sigma-Aldrich, 258148)
• Caution: Hydrochloric acid is extremely corrosive; handle with care and use appropriate personal protective equipment.
• Ethanol (Chem-Supply, EL043-2.5L-P)
• Poly-L-ornithine hydrobromide (Sigma-Aldrich, P3655) 
Patch Clamping Internal Solution Reagents
• Potassium D-gluconate (Sigma-Aldrich, G4500)
• Potassium chloride (Sigma-Aldrich, 60128)
• Sodium chloride (Sigma-Aldrich, S6191)
• HEPES sodium salt (Sigma-Aldrich, H3784)
• EGTA (Sigma-Aldrich, E3889)
• Guanosine 5 -triphosphate sodium salt hydrate (Na-GTP) (Sigma-Aldrich, G8877) • Adenosine 5 -triphosphate magnesium salt hydrate (Mg-ATP) (Sigma-Aldrich, A9187) • Important: The specific dilution (amount) of ERCC spike-ins added should be carefully optimized for each experimental setup to ensure that the number of added spike-in molecules is in proportion to the number of cellular RNA molecules (i.e., the experimental sample is not overspiked).
STEPWISE PROCEDURES
Preparation of Poly-L-Ornithine/Laminin-Coated Glass Coverslips for Neuronal Culture
Etching Coverslips (Acid Wash)
Note: Glass coverslip manufacturers commonly apply a superficial layer of silicone coating to reduce sticking tendency. Because such coating affects proper adherence of the neurons to the coverslip, acid washing is performed to remove the silicone through etching of the glass surface, making the glass a better substrate for cellular attachment. Extreme caution should be exercised with the handling of the strong acids in the protocol (indicated below).
(1) In a fume hood, fill the sonicator bath with Milli-Q water to about a thumb below the max line. (2) Place coverslips in a 1-l heavy duty borosilicate glass beaker.
Note: If using 24-well tissue culture plates, use 12-mm diameter coverslips; if using 48-well plates, use 8-mm diameter coverslips. (3) Fill glass beaker with Milli-Q water and swirl to rinse the coverslips. Then, pour off the water while being careful not to pour out the coverslips. (4) Repeat the previous rinsing step three more times. (5) Pour out as much of the remaining Milli-Q water as possible. Then, in the fume hood, fill the beaker with a sufficient volume (∼300 ml) of concentrated nitric acid to completely cover the coverslips and swirl. Caution: Nitric acid is extremely corrosive; handle with care and use appropriate personal protective equipment. (6) Wrap the top of the beaker in Parafilm, place the beaker in the sonicator bath, and sonicate (in the fume hood) for 60 min. Note: The sonicator must remain in the fume hood because of the acid fumes. (7) Dispose of the nitric acid in an appropriate waste collection bottle in the fume hood. (8) Wash the coverslips three times with Milli-Q water; be sure to swirl during each wash.
(9) Pour off the water from the last wash, add a sufficient volume (∼300 ml) of concentrated hydrochloric acid to completely cover the coverslips, and swirl. Caution: Hydrochloric acid is extremely corrosive; handle with care and use appropriate personal protective equipment. 
Culturing Human Neuronal Cultures on Coverslips
The aim of this section is to explain how to generate human neuronal cultures on glass coverslips for Patch-seq experiments. We applied this protocol to human midbrain neuronal cultures derived from embryonic and induced pluripotent stem cells (ESCs/iPSCs) (Bardy et al., 2015 ), but the procedures described can be easily adapted to other types of neuronal tissue [e.g., forebrain/cortical neurons (Zeng et al., 2010; Shi et al., 2012) ], or potentially even to non-neuronal tissues that are electrophysiologically interesting [e.g., cardiomyocytes (Ma et al., 2011; Davis et al., 2012) ].
Plating Neural Progenitor Cells (NPCs) for Differentiation
Embryoid body formation (Kim et al., 2011; Boyer et al., 2012) , monolayer culture (Chambers et al., 2009; Kim et al., 2011; Li et al., 2011) , and stromal feeder co-culture (Kawasaki et al., 2000; Kim et al., 2006) protocols represent the three mainstream procedures for the neuronal induction of human pluripotent stem cells. Detailed protocols have been published for the production of a variety of brain region-specific cell types [e.g., dopaminergic (Lee et al., 2000; Boyer et al., 2012; Zhang et al., 2014) , serotoninergic (Vadodaria et al., 2016; Xu et al., 2016) , forebrain/cortical (Zeng et al., 2010; Shi et al., 2012; Muratore et al., 2014) , and hippocampal dentate gyrus-like neurons (Mertens et al., 2015) ] from stem/progenitor states as well as adult somatic tissue. The NPC induction protocol that is most relevant to the experimental model should be used. Here, we applied the protocol from Boyer et al. (2012) to derive NPCs for subsequent differentiation into midbrain-like neuronal cultures:
(34) Prepare six-well plates with hESC-qualified Matrigel coating according to manufacturer's directions. (35) Culture NPCs on the Matrigel-coated six-well plates at high densities (∼2-4 × 10 6 cells per well). When passaging the cells, split at a ratio no higher than 1:3 about once every week.
• Pitfall: If human NPC cultures do not grow or grow very slowly, the NPCs were split (subcultured) too sparsely. Do not split the NPCs at a ratio higher than 1:3 as passaging these cells at too low confluency initiates their spontaneous differentiation. Ensure all cell lines are regularly tested to be free of mycoplasma contamination, as its presence may also negatively affect cell growth and proliferation.
(36) Feed NPCs every other day with 2 ml/well culture volume of fresh, 37 • C pre-warmed NPC medium. (f) Using a P1000 pipette, resuspend the cells in 
Differentiating and Maturing NPCs Into Functional Neurons
(39) After 24 h of recovery, gently replace half of the NPC medium with fresh, pre-warmed NDM to gradually initiate differentiation of the NPCs into midbrain-like neuronal subtypes. (40) Continue to gently replace half of the medium in the wells with an equal volume of fresh, pre-warmed NDM three times a week, taking care to minimize fluid perturbations that may affect proper maturation of the neurons.
• Pitfall: Occasionally neuronal cultures may detach from their coverslip after long period of time in vitro. To avoid this, when feeding the cultures, be sure to remove half of the old medium and add new medium very gently and slowly via the side of the well, being careful not to disturb the neuronal culture. Harsh feeding techniques may be causing too much medium turbulence on the cells. Also ensure that coverslips are etched and PORN/laminincoated according to the protocol as sub-optimal coating can also cause detaching (Steps 1-33).
(41) If functional analyses (e.g., patch clamping and calcium imaging) are to be performed, ensure to allow sufficient time (∼2-3 weeks at a minimum) for the neurons to develop strong synaptic contacts. Proper neuron generation can be immunohistochemically validated by staining for neuron-specific class III β-tubulin (using TUJ1 antibody) and the mature neuronal marker MAP2AB.
Decontamination of Patch-seq Equipment and Working Areas
Ribonucleases (RNases) are a type of enzyme that catalyzes the degradation of RNA. The minimal amount of RNA starting material in a single cell (∼10-30 pg) and the ubiquitous presence of several RNases require that an exceptional level of care must be taken to remove or inhibit any possible source of RNase contamination prior to and during lysis buffer preparation, single-neuron collection, and the pipetting of reverse-transcription mix reagents. In addition, due to the extreme sensitivity of the protocol, it is strongly recommended that the whole process up until the cDNA amplification step be carried out in a PCR-clean room (i.e., a room that never contains post-PCR amplification products) to avoid possible cross-contamination with cDNA from previous amplification reactions. The following steps describe how to clean all equipment and working areas in preparation for a Patch-seq experiment:
(42) With a spray bottle, apply RNase AWAY decontamination reagent to all equipment and working areas that will be touched with gloved hands during the experiment. Ensure the decontamination reagent contacts the entire surface by rubbing the wet area with a clean kimwipe, then use a fresh wipe to completely dry the surface. applying the same technique as described above, gently transfer the coverslip into the bath imaging chamber filled with freshly supplied medium. Lightly press down on the edge of the coverglass with the forceps to fully submerge the coverslip in the pre-warmed perfusate medium.
Electrophysiological and Morphological Neuronal Characterization
(49) Fill patch-clamping pipettes with intracellular recording solution containing a rhodamine dye (see the "Reagent Setup" section). The electrophysiological recordings should last ∼15-30 min to allow enough time for the rhodamine (or alternative dye) to diffuse throughout the distal parts of the dendrites and axon (Figure 1) . Perform whole-cell patch-clamp electrophysiology according to lab-preferred protocol. The specific protocols that we used to patch clamp in vitro human neurons derived from pluripotent stem cells are published in detail elsewhere (Bardy et al., 2015 . (50) Including biocytin in the internal solution will allow you to fix and co-stain the patched neurons with immunocytochemistry markers, as an alternative to RNAseq.
Micropipette Isolation of a Single Neuron After Patch Clamping
Once the patch clamping and imaging are completed (<30 min), apply negative pressure to the patch pipette and slowly withdraw the neuron from the rest of the culture. The entire neuron, including the soma, dendrites, and axon (Figure 1) , must be immediately transferred into the sample lysis buffer in an RNasefree collection tube:
(51) Apply negative pressure to the patch pipette to establish a strong seal with the neuron (−0.15 PSI). (52) Carefully retract the glass micropipette from the chamber bath while visualizing the rhodamine-tagged cell and pipette under the binocular of the microscope (40×). Adjust the focus up and down to make sure that long dendrites are coming along with the soma. The neuron should remain attached to the tip of the electrode ( Figure 1A) . Important: confirm successful removal of the entire neuron from the coverslip by taking 40× images before and after removal ( Figure 1B) . The neuronal culture may be tagged with a GFP reporter (e.g., lentiviral vector) and the single patched neuron with rhodamine. Before patch clamping, collect GFP and DIC images. During patching, collect DIC and rhodamine images. After single-neuron collection, collect DIC, GFP, and rhodamine images. In the event that collection of the entire neuron is ambiguous, e.g., due to rupture of the cell's elaborate neurites, the sample should be discarded from further processing.
• Pitfall: If the neuron does not want to lift off from the coverslip when retracting the patch pipette, despite applying negative pressure, the neuronal culture might be too dense and/or the cell to be collected is too big (relative to the patch electrode tip) or has very long and complex dendritic arborization. Pull a new patch pipette with a slightly larger electrode tip to collect the larger neuron. If neuron isolation remains difficult after multiple collection attempts, consider plating a lower number of NPCs onto the PORN/laminin-coated coverslips for neuronal differentiation to obtain cultures that are less dense.
(53) Transfer the entire neuron, including its processes, into the sample collection buffer of the PCR collection tube:
(a) Carefully remove the micropipette, with the neuron attached to its tip, from the pipette holder. (b) Transfer the neuron into the 8.0 µl of lysis buffer by submerging the patch electrode in the buffer and gently breaking its glass tip along the inside wall of the PCR collection tube. Ideally, the sharp point of the micropipette should be completely released into the buffer. (c) Insert a syringe into the top of the micropipette. Forcefully push down the plunger to effectively expel any remaining liquid contents out of the pipette. Gently remove the plunger and repeat fluid ejection one more time.
(54) Close the collection tube and spin in a microcentrifuge for 1 min to bring the contents to the bottom of the tube. Immediately place the tube back in the PCR cooler rack and proceed to cDNA synthesis of polyadenylated transcripts using Smart-seq-based chemistry. Because RNA is less stable than DNA, it is best to reverse transcribe each sample as soon as possible after collection. To accomplish this task, it is strongly recommended to have an experienced electrophysiologist work closely together with a molecular biologist, where the electrophysiologist is responsible for the patch clamping and sample collection, and the molecular scientist for performing immediate cDNA synthesis post sample collection. We do not recommend keeping collected samples on ice for extended periods of time (i.e., more than 1-2 h). Likewise, it is not recommended to freeze collected single cell samples prior to mRNA reverse transcription, as any freezethaw cycle will greatly accelerate degradation of the single-cell RNA. After cDNA synthesis, amplification and purification have been performed, the cDNA is stable and can be stored at ≤−20 • C for up to 6 months before analysis or the preparation of libraries for RNA sequencing.
Reverse Transcription of the Single-Cell RNA Note: The Smart-seq method on which this kit is based has recently made several improvements that have resulted in optimized reagents and protocols for reverse transcription in later version SMARTer kits. Always follow the specific manufacturer's instructions that come with the kit that is used. 
Purification and PCR Amplification of Full-Length cDNA
Note: The Smart-seq method on which this kit is based has recently made several improvements that have resulted in optimized reagents and protocols for cDNA amplification in later version SMARTer kits. Always follow the specific manufacturer's instructions that come with the kit that is used.
(63) Bring AMPure XP magnetic beads to room temperature and vortex well to completely resuspend the beads in the bead/buffer solution. for 3-5 min until the bead pellet appears dry (i.e., tiny cracks have become visible in the pellet). Be sure to dry the pellet enough, as any residual ethanol from under-dried sample will reduce the final cDNA yield. However, do not overdry the pellet as this will make it difficult to rehydrate and resuspend the beads in SMARTer purification buffer. (85) Remove the sample from the magnetic stand, add 12 µl of SMARTer purification buffer to cover the beads, and incubate for 2 min to rehydrate.
• Pitfall: If the magnetic beads are difficult to resuspend, the beads are over-dried. Do not wait for all sample pellets to appear completely dry before adding SMARTer purification buffer; over-drying of the beads can be avoided by purifying samples in smaller batches. cDNA from over-dried beads may still be recovered by covering the beads in purification buffer for an extended amount of time (>2 min).
(86) Pipette up and down 10 times to resuspend the beads and elute the cDNA. (87) Place the sample back on the magnetic separation device and incubate for 2 min until the beads are collected to the side of the tube and the solution is clear.
(88) With the sample sitting on the magnetic stand, transfer the clear supernatant (∼12 µl) to a non-stick, RNase-free microfuge tube.
Note: The purified amplified cDNA can be stored at ≤−20 • C for up to 6 months before continuing with QC analysis and library preparation.
QC of Single-Neuron cDNA
Thorough sample QC ensures that potentially spurious captures and/or contaminated samples can be readily identified and filtered out prior to proceeding with expensive transcriptome profiling. This section details a general workflow for the QC analysis of cDNA samples generated from captured single neurons using Smart-seq chemistry (Figure 2) . Note: The specific results obtained may vary slightly with the use of reagent kits that employ newer Smart-seq chemistry; the steps below demonstrate a general pipeline of QC analysis to be performed on single-cell cDNA. Always consult the user manual of your kit for specific recommendations.
(89) Profile the expression levels of at least two widely expressed housekeeping genes (e.g., GAPDH and ACTB) with standard quantitative real-time PCR (qRT-PCR):
(a) Order pre-formulated TaqMan Gene Expression Assays (primers) for your housekeeping genes to be assayed. We selected human beta actin (ACTB; Applied Biosystems, 4333762T) and GAPDH (Applied Biosystems, 4352934E) as endogenous controls. • Pitfall: If qRT-PCR analysis of ACTB and GAPDH housekeeping genes reveals no or very low (Ct > 30) expression, it is likely that the cell was lost from the pipette tip during retraction of the patch electrode from the chamber bath, or during its transfer into FIGURE 2 | Pipeline for single-neuron Patch-seq experiments.
Step 1: A single neuron is characterized at the functional and morphological level by whole-cell patch-clamp electrophysiology and imaging.
Step 2: Negative pressure is applied to the patch pipette used for electrophysiological recording, after which it is retracted from the chamber batch with the neuron still attached. The entire neuron, including its processes, is immediately transferred into lysis buffer by breaking the glass patch pipette tip along the inside wall of an RNase-free collection tube. Successful cell capture is always confirmed by microscopic evaluation (comparison of before and after pictures).
Step 3: Single-neuron mRNA, along with external reference transcripts (ERCC RNA spike-ins) present in the lysis buffer, is reverse transcribed and the cDNA is PCR-amplified using SMARTer chemistry.
Step 4: The synthesized cDNA is subjected to a series of QC steps based on three assays: (i) expression profiling of common housekeeping genes and RNA spike-ins by quantitative real-time PCR; (ii) fluorometric quantitation of cDNA yield (Qubit); and (iii) qualitative analysis of cDNA fragment profiles and contamination check (Bioanalyzer). Inability to detect expression of housekeeping genes while detecting expression of ERCCs is a sign of failed neuron capture, whereas inability to detect ERCCs signifies failed SMARTer cDNA synthesis. Contaminated samples are characterized by abnormally high cDNA yields that appear on the fragment analyzer as a broader peak with jaggedness or multiple peaks in the electropherogram (see also Figure 3 ).
Steps 5 and 6: Libraries for RNA-seq are prepared from samples passing all QC analyses and are sequenced on an Illumina HiSeq 2500 platform.
Step 7: Bioinformatics processing and analysis of the resulting RNA-seq data enable identification of unique genetic signatures associated with specific neuronal (sub)types.
the PCR tube. Alternatively, RNA from a successfully captured cell degraded due to RNase contamination of the sample or improper sample handling. Keep single-cell samples on ice at all times (unless indicated otherwise) and proceed with reverse transcription immediately after cell collection. Do not freeze samples before reverse transcription and cDNA amplification have been completed. Clean all lab benches, pipettors and equipment thoroughly with RNase AWAY decontamination solution every day, before starting experiments.
(90) Profile the expression levels of a high, medium, and low abundant ERCC spike-in RNA standard (included in the sample collection buffer as "ERCC RNA Spike-In Mix") with standard qRT-PCR using the same protocol as described above. Pre-designed TaqMan Gene Expression Assays for these external controls are available from Thermo Fisher Scientific. • Pitfall: If the baseline of the Bioanalyzer trace does not appear flat/straight, the magnetic beads have carried over into the cDNA sample: Any DNA bound to them will bind dye and affect the baseline fluorescence. Place the cDNA sample onto the magnetic stand for 5 min to attract any beads onto the tube wall. Using a small pipette tip, slowly transfer bead-free solution to a new microfuge tube while taking care not to disturb any beads into solution.
• Pitfall: If the cDNA fragment profile shows a large peak following the Bioanalyzer Lower Marker (<100 bp), carryover of primers or primer dimers has occurred. During cDNA purification, ensure that ethanol wash solutions are always prepared fresh and completely removed and that the magnetic beads are sufficiently dried to enable complete evaporation of residual ethanol before resuspension.
(b) Inspect the electropherogram for signs of contamination. Contaminated samples can be identified by distinctive electropherogram features: (i) an abnormally high yield, (ii) a broader than normal peak with increased cDNA amounts at lower bp sizes, and/or (iii) a "jagged" pattern or multiple peaks ( Figure 3A) . Samples with features indicative of contamination should be excluded from downstream library preparation and RNA-sequencing analysis. (c) Check for the presence of specific cDNA product in the range of 400-9,000 bp. Note: A sample generating good quality data is typically characterized by a shallow peak with a maximum at ∼2,000 bp and has no cDNA product at lower bp sizes ( Figure 3B ). 
Library Preparation
ANTICIPATED RESULTS
Using the patch-pipette micromanipulation technique detailed here, the likelihood of successful isolation of a single neuron figure) or an early rising peak with increased cDNA amount at lower base-pair sizes and a "jagged" pattern (middle and bottom). (B) Samples generating good-quality sequencing data have a shallow peak with a maximum at ∼2,000 bp (range ∼400-9,000 bp, specific region), no jaggedness, and no cDNA product at lower base pair size (non-specific region). Addition of ERCC RNA spike-in controls to the sample collection buffer may result in the appearance of additional peaks (indicated by asterisks).
from the culture substratum (as confirmed by microscopic evaluation; Figure 2, Step 2) is approximately 50%. It should be noted, however, that the actual success rate of removing a patch-clamped neuron from a coverslip may vary somewhat from laboratory to laboratory and even from culture to culture depending on the type of neurons grown, their density on and adherence to the coverslip, their thickness and size, and dendritic complexity as well as the experimenter's experience or proficiency with the isolation technique. Of all the samples captured (visually confirmed) and reverse transcribed, about 50% pass all QC at the cDNA level (Figure 2, Step 4), thus bringing the total success rate of obtaining sequencing-ready libraries from electrophysiologically characterized neurons to ∼25%. Following the protocol detailed here, 56 single neurons derived from healthy pluripotent stem cells (ESCs/iPSCs) were isolated and subjected to whole-transcriptome mRNA-seq profiling after passing all sample QC (see Bardy et al., 2016) .
Housekeeping Gene Expression
Although microscopic evaluation is used to confirm successful removal of the neuron from the coverslip, a cell can be lost from the pipette tip upon its retraction from the chamber bath due to the surface tension present at the perfusate-air interface.
A quantitative real-time PCR assay profiling the expression of a few housekeeping genes should provide comprehensive information as to whether a cell was successfully collected into the PCR tube. qRT-PCR analysis of cDNA reverse transcribed and amplified from effectively captured neurons reveals good expression of the housekeeping genes ACTB and GAPDH (Ct values ≤ 30), though at variable levels from cell to cell ( Figure 4A ). Samples with no or very low (Ct > 30) expression of housekeeping genes can be considered spurious. Such samples very likely represent failed captures, and therefore we recommend excluding them from downstream sequencing analysis. We readily detected expression of housekeeping genes with RNA-seq in cells that passed all QC checks in our pipeline ( Figure 4B) , and RNA-sequencing expression correlated highly with the qRT-PCR measurements ( Figure 4C ).
Expression of RNA Spike-in Standards
To assess the sample-specific technical performance of the mRNA reverse transcription and cDNA amplification reactions, synthetic reference transcripts (ERCC RNA spike-ins) should be mixed into the sample before cell collection and their expression analyzed after cDNA preparation ( Figure 5 ). Expression profiling of three different ERCC transcript species with qRT-PCR and FIGURE 4 | Natural variation in expression of housekeeping genes in single neurons. TaqMan quantitative real-time PCR was performed on SMARTer cDNA generated from n = 56 single human neurons successfully isolated for Patch-seq to profile the expression levels of ACTB and GAPDH housekeeping genes. ACTB and GAPDH were readily expressed though at variable levels from cell to cell as revealed by both qRT-PCR (A) and RNA-sequencing (B). (C) Single-neuron expression of ACTB and GAPDH housekeeping genes is highly correlated between qRT-PCR and RNA-sequencing measurements.
FIGURE 5 | Expression analysis of ERCC RNA spike-in controls to assess technical performance of SMARTer cDNA preparation. (A-C) Expression of a high-, medium-, and low-copy ERCC standard in n = 28 spiked cells measured by qRT-PCR and RNA-seq. Variability in expression increases with a decrease in absolute ERCC copy number. (D) Measured expression of ERCC RNA spike-ins as a function of the number of actual molecules added to each sample. The very small amount (∼10 pg) of RNA in a single cell requires a significant dilution of the ERCC stock to avoid overspiking of the experimental sample with exogenous transcripts. With a 1:5,000,000 dilution in the final master mix before reverse transcription, 73 ERCCs were present in at least one copy number, 71 of which were detected by RNA-seq across samples (n = 28). (E) The variation in measured ERCC expression levels is highest for low expressed (i.e., low abundant) ERCCs.
FIGURE 6 | Distribution of cDNA yields of sequencing-quality single neuron samples. Reverse transcription and 18-cycle PCR amplification of cDNA from single neurons using SMARTer resulted in yields of cDNA in the range of 0.14-2.97 (mean 0.70 ± 0.53) ng/µl. We found samples with substantially higher yields to be frequently contaminated (see also Figure 3 ).
sequencing reveals that sample-to-sample variation in expression is smallest for the highest copy number ERCC transcript but is increased for transcript species present at lower abundances ( Figures 5A-C) . Confirming the efficacy and non-specificity of the cDNA synthesis and amplification reactions, the absolute transcript abundances of the ERCC standards correlate very strongly with their normalized expression reads as measured by RNA-sequencing ( Figure 5D ). The dispersion in the variation in mean expression levels of ERCCs decreases with increased expression (and hence, abundance) of ERCC transcripts (Figure 5E ), in line with the qRT-PCR data. This is to be expected because there is less technical variability in the wetlab addition as well as the detection (RNA-sequencing) of ERCC transcripts of higher abundance. All in all, qRT-PCR analysis of the ERCC spike-ins represents a useful tool to quickly assess the quality of the single-cell transcriptome preparation prior to sequencing. As a word of caution, the concentration of spike-in controls such as ERCCs added to the sample collection buffer should be carefully adjusted to ensure that the majority of sequencing reads originate from the experimental sample and not from the added spike-ins. The ERCC spike-in stock should be diluted in such a way that the number of spike-in molecules added to each sample is in proportion to the number of cellular RNA molecules. Our 1:250,000 dilution of ERCC stock gives a final concentration of 1:5,000,000 in the final master mix before reverse transcription and results in the detection of 71 out of 92 ERCCs. One has to optimize the final concentration of ERCCs for the specific experiment, depending on factors such as the size of the cells and the number of transcripts typically expressed in the cell type to be collected. Quantity and Quality Analysis of Single-Cell cDNA
We found good-quality samples suitable for sequencing to have a cDNA concentration in the range of 0.14-2.97 (mean 0.70 ± 0.53) ng/µl (Figure 6 ). This represents the typical concentration range of cDNA that is obtained using 18-cycle PCR amplification with Smart-seq. Beware that newer kits employing improved Smart-seq chemistry likely produce higher cDNA yields. Additional inspection of the fragment profiles (Agilent 2100 Bioanalyzer) of various amplified cDNA samples shows that many samples with abnormally high cDNA yields (>3 ng/µl) are characterized by signs of contamination: a broader than normal peak with increased cDNA amounts at lower bp sizes, and a pattern of multiple peaks or "jaggedness" in the electropherogram (Figure 3A) . In contrast, good-quality (clean) samples show the presence of specific cDNA product in the 400-9,000 bp range (with a maximum at ∼2,000 bp), no jaggedness, and no low bp-sized cDNA product ( Figure 3B) . Thus, both a quantitative and qualitative assessment of Smart-seq-synthesized cDNA prior to library preparation and sequencing can be used to identify, and filter out, cell samples with a high likelihood of generating low-quality data.
Timing of the Protocol
Throughput is the major limitation of Patch-seq as it takes time to patch, image, and collect a single cell. In our experience, an experienced electrophysiologist and molecular biologist working closely together can successfully record, collect, and process (reverse-transcribe and amplify) 3-4 cells per day (out of six to eight total cells patched). This amounts to 15-20 cells per week that can be collected and subjected to downstream QC. 
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